2025 HCPCS Code J2920
Injection, methylprednisolone sodium succinate, up to 40 mg
TAGS: sodium methylprednisolone| Notice | HCPCS J2920 terminated on March 31, 2024. |
| Short Description | Methylprednisolone injection |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 01, 1982 |
| HCPCS Action Effective Date | April 01, 2024 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J2280 - Inj, moxifloxacin 100 mg
- J2281 - Inj moxifloxacin (fres kabi)
- J2300 - Inj nalbuphine hydrochloride
- J2305 - Inj, nitroglycerin, 5 mg
- J2310 - Inj naloxone hydrochloride
- J2311 - Inj, naloxone hcl (zimhi)
- J2315 - Naltrexone, depot form
- J2320 - Nandrolone decanoate 50 mg
- J2323 - Natalizumab injection
- J2325 - Nesiritide injection
- J2326 - Inj, nusinersen, 0.1mg
- J2327 - Inj risankizumab-rzaa 1 mg
- J2329 - Inj ublituximab-xiiy, 1 mg
- J2350 - Injection, ocrelizumab, 1 mg
- J2353 - Octreotide injection, depot
- J2354 - Octreotide inj, non-depot
- J2355 - Oprelvekin injection
- J2356 - Inj tezepelumab-ekko, 1mg
- J2357 - Omalizumab injection
- J2358 - Olanzapine long-acting inj